TuisZEAL • CPH
add
Zealand Pharma A/S
Vorige sluiting
kr 500,60
Dagwisseling
kr 477,10 - kr 502,60
Jaarwisseling
kr 306,10 - kr 893,00
Markkapitalisasie
35,73 mjd DKK
Gemiddelde volume
306,37 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
CPH
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (DKK) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 9,09 mjd | 26 527,65% |
Bedryfskoste | 749,45 m | 156,38% |
Netto inkomste | 7,57 mjd | 2 687,07% |
Netto winsgrens | 83,33 | 109,72% |
Wins per aandeel | 105,61 | 2 361,46% |
EBITDA | 8,34 mjd | 3 298,22% |
Effektiewe belastingkoers | 6,62% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (DKK) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 16,58 mjd | 85,59% |
Totale bates | 17,18 mjd | 69,17% |
Totale aanspreeklikheid | 1,57 mjd | 106,88% |
Totale ekwiteit | 15,61 mjd | — |
Uitstaande aandele | 70,38 m | — |
Prys om te bespreek | 2,26 | — |
Opbrengs op bates | 158,51% | — |
Opbrengs op kapitaal | 168,73% | — |
Kontantvloei
Netto kontantverandering
| (DKK) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 7,57 mjd | 2 687,07% |
Kontant van bedrywe | 8,52 mjd | 3 782,77% |
Kontant van beleggings | -1,57 mjd | -5 074,21% |
Kontant van finansiering | -309,75 m | -104,59% |
Netto kontantverandering | 6,47 mjd | -0,23% |
Beskikbare kontantvloei | 5,95 mjd | 2 247,55% |
Meer oor
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Gestig
01 Apr. 1997
Webwerf
Werknemers
424
